Kuwait Pharmaceuticals and Healthcare Report Q4 2014

Business Monitor International
October 22, 2014
122 Pages - SKU: BMI5361535
Countries covered: Kuwait

Kuwait Pharmaceuticals and Healthcare Report Q4 2014

BMI View: Notwithstanding a recent escalation in political uncertainty, Kuwait's healthcare sector isforecast to preserve its trajectory of modest growth throughout the remainder of 2014. Rising sales areunderpinned by an expanding population, whose levels of chronic conditions increasingly call for thesupply of long-term treatments and cutting-edge medical equipment. In addition, apprehension towards fakegenerics and an accompanying government crackdown have further solidified popular demand for brandeddrugs. However, a confusing bureaucracy and sluggish implementation of key foreign direct investment andintellectual property reform will continue to dampen overall investment and restrain Kuwait from matchingthe pace of other emerging economies.

Headline Expenditure Projections

Pharmaceuticals: KWD290mn (USD1.02bn) in 2013 to KWD306mn (USD1.10bn) in 2014; +5.6% inlocal currency terms and +7.6% in US dollar terms. Forecast unchanged from Q3 2014.

Healthcare: KWD1.43bn (USD5.03bn) in 2013 to KWD1.56bn (USD5.58bn) in 2014; +8.8% in localcurrency terms and +10.8% in US dollar terms. Forecast unchanged from Q3 2014.



More Prescription Drugs reports by Business Monitor International

Japan Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Japan Pharmaceuticals and Healthcare Report Q1 2015BMI View: The Japanese pharmaceutical market continues to hold strong rewards for innovativepharmaceutical companies. This is driven by the ...
Tanzania Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Tanzania Pharmaceuticals and Healthcare Report Q1 2015BMI View: We expect the continuing depreciation of the Tanzanian shilling to make imports of rawmaterials increasingly expensive for ...
Romania Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Romania Pharmaceuticals and Healthcare Report Q1 2015BMI View: Romania's claw back tax is likely to see a revision as domestic companies lobby to push theburden ...
Latvia Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Latvia Pharmaceuticals and Healthcare Report Q1 2015BMI View: Market growth forecasts are strong although the country will continue to present a modestopportunity to larger multinational ...
See all reports like this >>

More Kuwait Prescription Drugs reports

Pharmaceuticals and Healthcare Report - Kuwait - Q3 2014 by Business Monitor International
Kuwait Pharmaceuticals and Healthcare Report Q3 2014BMI View: Despite upcoming by-elections, Kuwait's economy is forecast to post moderate growth in 2014,and the prospects for consumption ...
KUWAIT Healthcare & Pharmaceuticals 2013 by Noozz Research
KUWAIT Healthcare & Pharmaceuticals 2013Kuwait’s healthcare and pharmaceutical industries, which are dominated by high levels of government expenditure, and a robust, free public healthcare service ...
See all reports like this >>

More Kuwait reports

D&B Country Report: Kuwait by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
See all reports like this >>

 

SELECT A LICENSE

    Report with 3 quarterly updates  USD 1,295  
    Report with 3 quarterly updates
3 User License
  USD 1,945  
    Report with 3 quarterly updates
5 User License
  USD 2,500  
    Report with 3 quarterly updates
Departmental/Site License
  USD 2,995  
    Global Site License Fulfilled by Publisher  USD 6,995  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!